Human umbilical vein endothelial cells (HUVECs) were harvested from fresh umbilical cords following a previously established protocol (Ghajar et al., 2006 (
link)). HUVECs were plated with endothelial growth media (
EGM-2, Lonza, Walkersville, MD) in tissue culture flasks and cultured at 37 °C and 5% CO
2. Media were changed every 48 hours and cells were used at passage 3. Normal human lung fibroblasts (
NHLFs, Lonza) were cultured at 37 °C and 5% CO
2 in
Dulbecco’s modified eagle media (DMEM, Life Technologies, Grand Island, NY) with 10% fetal bovine serum (FBS). Culture media were replaced every 48 hours and cells from passage 6–10 were used in experiments. iCell endothelial cells (Cellular Dynamics International, Madison, WI), referred to as iPSC-ECs, were cultured at 37 °C and 5% CO
2 in
Vasculife VEGF endothelial medium (Lifeline Cell Technology, Fredrick, MD) supplemented with iCell Endothelial Cell Medium Supplement (Cellular Dynamics International), per the manufacturer’s instructions. iPSC-EC’s tissue culture flasks were coated with 35 μg/mL
fibronectin (Invitrogen, Carlsbad, CA) for 1 hr at room temperature prior to plating the cells. Culture media were replaced every 48 hours and cells from passage 3 were used in experiments.
Bezenah J.R., Rioja A.Y., Juliar B., Friend N, & Putnam A.J. (2018). Assessing the ability of human endothelial cells derived from induced pluripotent stem cells to form functional microvasculature in vivo. Biotechnology and bioengineering, 116(2), 415-426.